Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Pascale Belguise

Pascale Belguise

Director of Business Development, Polyplus-transfection

Pascale Belguise is graduated in Organic Chemistry from the “Lyon Engineer School of Chemistry” (Lyon, France) (1986). Following this degree, Pascale Belguise worked for one year as a Research assistant at the Wayne State University of Detroit (Michigan) on the chemical modification of nucleoside. Then, she received her Ph.D. in Molecular Biology in 1993 from the University of Strasbourg working on the molecular mechanism of mutagenesis in bacteria. In 1996, she joined the Laboratory of Genetic Chemistry, directed by Prof Jean-Paul Behr, as a post-doctoral scientist to work on the targeting of synthetic vectors for gene transfer.

In 2001, Pascale Belguise joined Polyplus-transfection as it was founded. She is directing the Business development, which includes development of new products, management of business partnerships, support of the Gene and Cell Therapy customers and participation to the corporate strategy.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd